Hosted on MSN2mon
Stryker Gains 30.2% Year to Date: What's Driving the Stock?Strength in Stryker’s flagship Mako Total Knee Platform, which enables surgeons to do pre-operative planning and precise surgeries, looks promising. The company is also adopting several cost ...
Once complete, the new company will have exclusive access to Stryker’s Mako Spine robotic-assisted surgical device and Copilot surgical assistance technology for use with VB Spine’s implants.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results